Kazakhstan vs Seychelles: Prevalence rate of hypertension in women aged 30-79
Kazakhstan
42.5
in 2019
Seychelles
42.3
in 2019
Kazakhstan rank
43rd
Seychelles rank
46th
Prevalence rate of hypertension in women aged 30-79 over time
- Kazakhstan
- Seychelles
How they compare
Kazakhstan currently reports 42.5 against 42.3 in Seychelles, a difference of 0.2.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Seychelles ahead.
Kazakhstan ranks 43rd and Seychelles ranks 46th of 195 countries.
Seychelles has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Seychelles | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 40.29 | 43.56 | 3.27 | Seychelles |
| 2000s | 41.78 | 44.37 | 2.59 | Seychelles |
| 2010s | 42.77 | 43.66 | 0.89 | Seychelles |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Kazakhstan or Seychelles?
- Kazakhstan, at 42.5 against 42.3 in Seychelles as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Kazakhstan and Seychelles?
- 0.2, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Seychelles?
- 30 years are reported by both, from 1990 to 2019.
- How do Kazakhstan and Seychelles rank globally for prevalence rate of hypertension in women aged 30-79?
- Kazakhstan ranks 43rd and Seychelles ranks 46th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.